✦ LIBER ✦
11 Vedolizumab induction therapy for patients with Crohn's disease and prior anti-tumour necrosis factor antagonist failure: a randomised, placebo-controlled, double-blind, multicentre trial
✍ Scribed by Sands, B.; Feagan, B.; Rutgeerts, P.; Colombel, J.-F.; Sandborn, W.; Sy, R.; D'Haens, G.; Ben-Horin, S.; Xu, J.; Fox, I.; Parikh, A.; Milch, C.; Hanauer, S.
- Book ID
- 123570653
- Publisher
- Oxford University Press
- Year
- 2013
- Tongue
- English
- Weight
- 230 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1873-9946
No coin nor oath required. For personal study only.